1. Home
  2. GENB vs PRGO Comparison

GENB vs PRGO Comparison

Compare GENB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.64

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$13.04

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENB
PRGO
Founded
2018
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
GENB
PRGO
Price
$15.64
$13.04
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$23.20
$19.33
AVG Volume (30 Days)
476.8K
3.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
10.28%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.58
$1.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$9.23
52 Week High
$18.18
$24.61

Technical Indicators

Market Signals
Indicator
GENB
PRGO
Relative Strength Index (RSI) 59.66 65.56
Support Level $11.82 $12.45
Resistance Level $16.75 $13.89
Average True Range (ATR) 0.84 0.51
MACD 0.18 0.19
Stochastic Oscillator 98.18 76.99

Price Performance

Historical Comparison
GENB
PRGO

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

About PRGO Perrigo Company plc

Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: